Neuralink gets approval to start human trials in Canada
Briefly

Neuralink's CAN-PRIME study will assess the safety of its implant and enable quadriplegic participants to control devices with their thoughts, without physical movement.
Health Canada has approved Neuralink to begin human trials in Canada, focusing on embedding brain implants that allow participants to control technology simply with their neural activity.
The first patient reported that while experiencing issues with the implant's threads initially, he now feels well and plans to demonstrate the technology's capabilities.
Neuralink is actively recruiting individuals with limited hand functionality due to spinal cord injuries or ALS to participate in its Canadian clinical trials.
Read at Engadget
[
|
]